Related Experiment Video
Updated: May 26, 2025

03:05
Author Spotlight: Advancing Early Detection and Treatment of Gastrointestinal Tumors
Published on: February 16, 2024
956
New machine-learning models outperform conventional risk assessment tools in Gastrointestinal bleeding
Eszter Boros1,2, József Pintér3, Roland Molontay3,4
1Institute for Translational Medicine, Medical School, University of Pécs, Pécs, Hungary.
Scientific Reports
|February 21, 2025
Summary
Machine learning models accurately predict in-hospital mortality risk in acute gastrointestinal bleeding (GIB) patients. XGBoost and CatBoost outperformed traditional scoring systems, improving patient risk stratification.
Area of Science:
- Medical Informatics
- Clinical Prediction Models
- Gastroenterology
Background:
- Accurate identification of high-risk patients with acute gastrointestinal bleeding (GIB) is critical for timely intervention.
- Existing clinical scoring systems may have limitations in predicting in-hospital mortality for GIB patients.
Purpose of the Study:
- To develop and evaluate machine learning (ML) models for predicting in-hospital mortality in patients admitted with overt GIB.
- To compare the performance of ML models against established clinical risk scores.
Main Methods:
- Analysis of a prospective, multicenter Hungarian GIB Registry dataset including 1,021 patients.
- Development and validation of XGBoost and CatBoost ML models.
- Comparison of ML models with Glasgow-Blatchford (GBS), pre-endoscopic Rockall, and ABC scores using five-fold cross-validation and AUC analysis.
Main Results:
- XGBoost and CatBoost models demonstrated superior predictive performance for in-hospital mortality compared to GBS and Rockall scores.
- Area Under the Curve (AUC) values for XGBoost and CatBoost were 0.84 and 0.77, respectively, significantly higher than GBS (0.68) and Rockall (0.62).
- The ABC score achieved an AUC of 0.77, still lower than the ML models.
Conclusions:
- XGBoost and CatBoost ML models offer improved accuracy in assessing mortality risk for acute GIB patients.
- These ML models provide a more effective tool for risk stratification than conventional clinical scoring systems.
- The findings support the integration of ML-based tools for enhanced clinical decision-making in GIB management.

